University of California, Irvine: clinical-trial pipeline
University of California, Irvine is the sponsor of 473 clinical trials in ClinicalTrials.gov and the EU CTIS portal; 117 are not yet finished and 6 were first posted in the last 90 days. Source: Arcadium Data, data as of .
Trials by phase
| Phase | Trials |
|---|---|
| Not applicable | 326 |
| Phase 2 | 54 |
| Phase 1 | 32 |
| Phase 4 | 24 |
| Early phase 1 | 16 |
| Phase 1/2 | 12 |
| Phase 3 | 8 |
| Phase 2/3 | 1 |
Trials by status
| Status | Trials |
|---|---|
| Completed | 244 |
| Recruiting | 79 |
| Withdrawn or not authorised | 67 |
| Terminated | 31 |
| Active, not recruiting | 24 |
| Not yet recruiting | 14 |
| Unknown | 12 |
| Suspended or halted | 2 |
Condition areas
| Area | Trials |
|---|---|
| Oncology | 127 |
| Nephrology and urology | 51 |
| Cardiovascular | 44 |
| Neurology | 34 |
| Metabolic and endocrine (diabetes, obesity) | 33 |
| Gastroenterology and liver | 29 |
| Dermatology | 28 |
| Infectious disease and vaccines | 26 |
| Women's health and obstetrics | 26 |
| Psychiatry and mental health | 22 |
| Musculoskeletal | 20 |
| Rare and genetic diseases | 18 |
Countries
| Country | Trials |
|---|---|
| United States | 448 |
| Kenya | 2 |
| Canada | 1 |
| India | 1 |
Latest changes
| Day | Change | Trial |
|---|---|---|
| 2026-09-18 | New trial posted | PilotStudyAssessSafeActiveSurveillancApproachLocalThe Pa w/BrainMetsUndergoinCNSPenetratS… |
| 2026-09-17 | New trial posted | Nerve Block for Severe Abdominal Pain in the Emergency Department |
| 2026-09-15 | New trial posted | Phase II Elderly/Frail Pts With Newly Diagnosed or Recurrent Malignant Glioma Treated Wit… |
| 2026-09-14 | New trial posted | Epcoritamab as Consolidation Therapy for High-Risk Pts w/CLL on BTKI |
| 2026-08-31 | New trial posted | Ph II Intraperitoneal Paclitaxel + System Therapy in GI Ca w/Peritoneal Carcinomatosis (S… |
| 2026-08-26 | New trial posted | Patient-reported Outcomes-driven Supportive Care Navigation Among Hispanic/Latinx Cancer… |
Open trials
The 25 most recently changed open trials.
| Registry id | Title | Phase | Status | Countries |
|---|---|---|---|---|
| NCT06952725 | Chatbot for Online Support Groups to Treat Tobacco Addiction | Not applicable | Not yet recruiting | |
| NCT07209917 | Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India | Not applicable | Recruiting | India |
| NCT05844865 | Patient Derived Vascularized MicroTumor Model of Gastrointestinal Peritoneal Carcinomatosis | Not applicable | Recruiting | United States |
| NCT07819214 | Epcoritamab as Consolidation Therapy for High-Risk Pts w/CLL on BTKI | Phase 2 | Not yet recruiting | United States |
| NCT07827001 | PilotStudyAssessSafeActiveSurveillancApproachLocalThe Pa w/BrainMetsUndergoinCNSPenetratSystemicThe | Not applicable | Recruiting | United States |
| NCT04971954 | Using Nicotine to Reverse Age-related Auditory Processing Deficits | Not applicable | Recruiting | United States |
| NCT00764920 | Skin Imaging With Technologies in Development | Not applicable | Active, not recruiting | United States |
| NCT04920032 | Study of ctDNA Guided Change in Tx for Refractory Minimal Residual Disease in Colon Adenocarcinomas | Phase 1 | Recruiting | United States |
| NCT05600842 | De-escalated Radiation for Human Papillomavirus-Positive Squamous Cell Carcinoma of the Oropharynx | Not applicable | Recruiting | United States |
| NCT06552728 | The Effects of Energy Healing in Fibromyalgia | Not applicable | Recruiting | United States |
| NCT07042152 | Wearable Device and Behavioral Support for Enhancing Arm Use After Stroke | Not applicable | Recruiting | United States |
| NCT05046821 | Sporadic Inclusion Body Myositis Natural History Study | Not applicable | Active, not recruiting | United States |
| NCT07167862 | Optimizing Preeclampsia Postpartum With Point-of-care Ultrasound | Phase 4 | Not yet recruiting | United States |
| NCT07527325 | Fianlimab&Cemiplimab as TotalNeoadj The (TNT) ForMelanoma | Phase 2 | Not yet recruiting | United States |
| NCT04472767 | Cabozantinib Combined With Ipilimumab/Nivolumab and TACE in Patients With Hepatocellular Carcinoma | Phase 2 | Recruiting | United States |
| NCT07711691 | Empowering Patients' Lung Cancer Screening Uptake (Empower LCS/Call+) | Not applicable | Recruiting | United States |
| NCT06028828 | Risk-ADAPTed Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation | Phase 2 | Recruiting | United States |
| NCT06821178 | My Life and My Experiences Project | Not applicable | Recruiting | United States |
| NCT04737616 | Continuous Monitoring and Management of Vaginal Health Via Multifunctional OCT/OCTA/OCE Endoscopy | Not applicable | Active, not recruiting | United States |
| NCT06340906 | Electroacupuncture in Symptom Management After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoth… | Not applicable | Active, not recruiting | United States |
| NCT06446648 | Impact of Intraoperative ICG on Functional Outc in RARP | Early phase 1 | Recruiting | United States |
| NCT07064018 | Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies | Phase 1/2 | Recruiting | United States |
| NCT04861103 | Anticoagulation Profile in Pregnant Women Treated With Three Times a Day of Low Molecular Weight Heparin (LMW… | Phase 4 | Recruiting | United States |
| NCT04812093 | Spectroscopic Evaluation of Middle Ear Infection | Not applicable | Recruiting | United States |
| NCT07549958 | PhIbRandomGemcitabine(G)w/or w/Out Pitavastatin(P)MainTx UnresecPancreaticAdenocarcinoma(uPDAC) | Phase 1 | Recruiting | United States |
All sponsors: clinical-trial pipeline by sponsor.
Track a sponsor's pipeline
The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.
Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.
Cite as: Arcadium Data, "University of California, Irvine clinical trials: 117 open, 9 in phase 3", https://arcadiumdata.io/clinical-trials/sponsor/university-of-california-irvine/, data as of 2026-10-25.